LEADER 01628oam  2200385   450 
001 9910707992303321
005 20170815085422.0
035   $a(CKB)5470000002468642
035   $a(OCoLC)968792727
035   $a(EXLCZ)995470000002468642
100   $a20170117d2016      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aExamining implementation of the Biologics Price Competition and Innovation Act $ehearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016
210  1$aWashington :$cU.S. Government Publishing Office,$d2016.
215   $a1 online resource (iii, 83 pages)
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
300   $a"Serial No. 114-114."
320   $aIncludes bibliographical references.
517   $aExamining implementation of the Biologics Price Competition and Innovation Act 
606   $aBiologicals$xGovernment policy$zUnited States
606   $aPharmaceutical biotechnology$xGovernment policy$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aBiologicals$xGovernment policy
615  0$aPharmaceutical biotechnology$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707992303321
996   $aExamining implementation of the Biologics Price Competition and Innovation Act$93526765
997   $aUNINA